SECsense Logo

SpringWorks Therapeutics 8-K Filing Report: Key Insights and Updates

$SWTX
Form 8-K
Filed on: 2025-02-20
Source
SpringWorks Therapeutics 8-K Filing Report: Key Insights and Updates

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: February 20, 2025
  • Entity Name: SpringWorks Therapeutics, Inc.
  1. SEC Identification:
  • CIK (Central Index Key): 0001773427
  • SEC File Number: 001-39044
  • IRS Employer Identification Number (EIN): 83-4066827
  1. Company Information:
  • Headquarters Address: 100 Washington Blvd, Stamford, CT 06902
  • Contact Number: 203-883-9490
  1. Stock Information:
  • Stock Ticker: SWTX
  • Exchange: NASDAQ
  • Common Stock Par Value: $0.0001 per share
  1. Reporting Period:
  • Start Date: February 20, 2025
  • End Date: February 20, 2025

Insights:

  • The filing is an 8-K, which typically reports unscheduled material events or corporate changes. This suggests that important information regarding SpringWorks Therapeutics, Inc. was disclosed on this date.
  • The company is publicly traded on NASDAQ, indicating it is subject to SEC regulations and public scrutiny.
  • The report's date aligns with the period of reporting, which may indicate that it pertains to a specific event occurring on that date rather than a broader financial statement.

This analysis indicates that investors or stakeholders should review the details of the 8-K filing for any significant developments or events that may impact the company’s operations or financial condition.